In traditional drug development, randomized controlled trials (RCTs) are widely regarded as the gold standard for establishing safety and efficacy. But when working with emerging therapies—particularly federally restricted plant-based medicines such as cannabis, psilocybin, and other psychedelics—clinical trials are not always the first or most feasible step. That’s where real-world observational studies play a critical role. What Is a Clinical Trial? Clinical trials are high

A vibrant depiction contrasting the serenity of nature on the left with a technological exploration of the human mind on the right,...

In recent years, an unconventional trend has emerged in the corporate world: the use of psychedelics by executives seeking to enhance...

Conducting clinical trials on psilocybin faces several roadblocks, primarily due to its legal status, regulatory challenges, and the...